The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.
Beteiligte Einrichtungen
Abstract
Psoriasis is associated with health-related quality-of-life impairment and depression.
Bibliografische Daten
| Originalsprache | Deutsch |
|---|---|
| Aufsatznummer | 5 |
| ISSN | 0190-9622 |
| Status | Veröffentlicht - 2010 |
| pubmed | 20219265 |
|---|
